Effects of sprouted fenugreek seeds on blood glucose level in type 2 diabetic patients with/without hepatitis C virus

Abstract

Trigonella foenum-graecum, the plant that is commonly recognized for fenugreek, has antibacterial, antinociceptive, and hypocholesterolemia benefits. Thus, the purpose of the current research was to form an opinion of the outcome of sprouted fenugreek seeds on glycosylated hemoglobin (HbA1C) and blood glucose levels (BGLs) in those with type 2 diabetes (T2D) with and without viral hepatitis C (HCV). Three categories were randomly assigned from among ninety male and female T2DPs who had been diagnosed for toward minimum of six months and were receiving insulin and oral medication treatment: group 1 (control), category 2 (T2D with HCV), and denomination 3 (T2D without HCV). After the second month, group 2's fast blood sugar (FBS) values were substantially dropped according to statistical analysis (P = 0.0485) and the 3rd month (P = 0.0207). Following the third month, Group 3's FBS concentrations substantially dropped (P = 0.0362). However, HbA1C values significantly reduced in both set 2 (P = 0.0252) and collection3 (P = 0.0481) after the 3rd month. In diabetics with hepatitis C, sprouted fenugreek seeds substantially reduced FBS levels, but there was no discernible difference in FBS and HbA1C levels between the two groups. Body mass index (BMI) values decreased in all groups throughout the study, although the changes were not statistically significant. In conclusion, individuals with Type 2 diabetes, whether or not they have HCV, may benefit from adding sprouted fenugreek seeds to their treatment program in addition to meal modification and physical activity.